0001209191-21-065327.txt : 20211117
0001209191-21-065327.hdr.sgml : 20211117
20211117203018
ACCESSION NUMBER: 0001209191-21-065327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211115
FILED AS OF DATE: 20211117
DATE AS OF CHANGE: 20211117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Ian
CENTRAL INDEX KEY: 0001753281
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38672
FILM NUMBER: 211422294
MAIL ADDRESS:
STREET 1: C/O ARVINAS, INC., 5 SCIENCE PARK
STREET 2: 395 WINCHESTER AVENUE
CITY: NEW HAVEN
STATE: CT
ZIP: 0651
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARVINAS, INC.
CENTRAL INDEX KEY: 0001655759
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472566120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 203-535-1456
MAIL ADDRESS:
STREET 1: 395 WINCHESTER AVE
STREET 2: 5 SCIENCE PARK
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS INC.
DATE OF NAME CHANGE: 20181001
FORMER COMPANY:
FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC
DATE OF NAME CHANGE: 20151015
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-15
0
0001655759
ARVINAS, INC.
ARVN
0001753281
Taylor Ian
C/O ARVINAS, INC.
5 SCIENCE PARK, 395 WINCHESTER AVE.
NEW HAVEN
CT
06511
0
1
0
0
Chief Scientific Officer
Common Stock
2021-11-15
4
M
0
12206
16.00
A
90851
D
Common Stock
2021-11-15
4
M
0
7794
19.36
A
98645
D
Common Stock
2021-11-15
4
S
0
6856
83.0673
D
91789
D
Common Stock
2021-11-15
4
S
0
6660
84.1429
D
85129
D
Common Stock
2021-11-15
4
S
0
6484
84.9545
D
78645
D
Stock Option (right to buy)
16.00
2021-11-15
4
M
0
12206
0.00
D
2028-09-25
Common Stock
12206
8943
D
Stock Option (right to buy)
19.36
2021-11-15
4
M
0
7794
0.00
D
2029-02-28
Common Stock
7794
57633
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.66 to $83.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.66 to $84.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.66 to $85.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested on March 31, 2019 with the remainder of the shares vesting in equal monthly installments through March 31, 2022.
This option award was granted on March 1, 2019. 1/4 of the shares underlying the award vested on March 1, 2020, with the remainder of the shares vesting in equal monthly installments through March 1, 2023.
/s/ Matthew Batters, as attorney-in-fact for Ian Taylor
2021-11-17